Parse Biosciences Raises $41.5M Series B Round to Scale Single-Cell Sequencing Products and Expand Product Portfolio

Company to commercialize and create single-cell multi-omics products

SEATTLE, Feb 16 (Bernama-BUSINESS WIRE) — Parse Biosciences, a company dedicated to providing scalable single-cell sequencing solutions, today announced $41.5M in Series B funding co-led by Marshall Wace and Janus Henderson Investors. Soleus Capital, Logos Capital and Bioeconomy Capital also participated in the round, bringing Parse Biosciences’ total funding to date to over $50M.

http://mrem.bernama.com/viewsm.php?idm=42431

administrator

Related Articles